Generations of men underwent prostate cancer tests during an aggressive screening regimen. Then, the screenings stopped. Now doctors are reevaluating just how worried men should be about their prostate.
Men with prostate cancer want to know the future: Will my cancer get worse? Do I need surgery? Genomic testing can help us make educated recommendations, but it’s far from perfect. UT Southwestern explains why genomic testing isn’t a “crystal ball” for predicting prostate cancer risk.
UT Southwestern is using a new, targeted biopsy method for prostate cancer that’s more effective than standard biopsies – and they’ve just reached a significant milestone.
